<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Equity Diversity and Inclusion

Community    Equity Diversity and Inclusion

CU Cancer Center Leader Contributes to American Association for Cancer Research’s New Report on Health Equity

Jamie L. Studts, PhD, co-leader of the University of Colorado Cancer Center’s Cancer Prevention and Control Program, has devoted much of his research career to studying inequities in lung cancer risk factors, screening, treatment, and survivorship.


Author Greg Glasgow | Publish Date May 22, 2024
Full Story

Press Releases    Equity Diversity and Inclusion    Leadership

CU Cancer Center Expands DEIA Efforts With Hire of Associate Director and Deputy Associate Director 

The University of Colorado Cancer Center is doubling down on its diversity, equity, inclusion, and access (DEIA) efforts in 2023, adding an associate director and deputy associate director of DEIA to its leadership team. 


Author Greg Glasgow | Publish Date August 17, 2023
Full Story

Research    Community    Equity Diversity and Inclusion

NCI National Cancer Plan: Optimize the Workforce 

Whether they are focused on middle school and high school students, college undergraduates, or current medical students, pipeline programs at the University of Colorado Cancer Center are designed to expose students of all ages and backgrounds to the world of cancer science and research, with a special focus on giving students from underrepresented backgrounds the opportunity to see themselves working in the field.


Author Greg Glasgow | Publish Date July 21, 2023
Full Story

Community    Equity Diversity and Inclusion

CU Cancer Center Part of Global Effort to Close the Care Gap

About one in five people worldwide will develop cancer in their lifetimes and in 2020, the most recent year for which data are available, cancer accounted for nearly 10 million deaths worldwide.


Author Rachel Sauer | Publish Date February 04, 2023
Full Story

Community    Cancer    Magazine    Equity Diversity and Inclusion    ColoradoSPH at CU Anschutz    Leadership   

Women Are Gaining Increasing Seats at the Table in Cancer Leadership

Two important numbers to keep in mind are that 50.5% of the U.S. population is female, and that cancer will account for more than 606,000 deaths in the United States this year, making it the second-leading cause of death.


Author Rachel Sauer | Publish Date November 28, 2022
Full Story

Research    Education    Community    Equity Diversity and Inclusion

PIKE-PREP Supports Scholars from Underrepresented Backgrounds in Pursuing Top-Tier Education

Xander Bradeen began his undergraduate studies at the University of Colorado Boulder planning to major in neuroscience as a pre-med student, the first in his family to pursue a college education. Then he learned about prairie voles.


Author Rachel Sauer | Publish Date November 14, 2022
Full Story

Equity Diversity and Inclusion    ColoradoSPH at CU Anschutz   

Recognizing Health Disparities During National Minority Cancer Awareness Month 

April has been designated National Minority Cancer Awareness Month to bring attention to the health disparities that lead to higher rates of cancer in Black, Hispanic, American Indian/Alaskan Native, and other communities of color. 


Author Greg Glasgow | Publish Date April 08, 2022
Full Story

Research    Community    Faculty    Equity Diversity and Inclusion    ColoradoSPH at CU Anschutz   

Rising Star Position Will Support Health Disparities and Shared Decision-Making Research

While conducting research for her doctoral dissertation, Channing Tate, PhD, MPH, spoke with 144 older Black adults about hospice care – what they knew about it, whether they’d consider it, what their experiences with hospice had been.


Author Rachel Sauer | Publish Date March 25, 2022
Full Story

CU Cancer Center In the News

Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the Colorado University Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story
Cancer Therapy Advisor

Telisotuzumab Vedotin Yields Durable Responses in c-Met-Expressing NSCLC

news outletCancer Therapy Advisor
Publish DateJune 07, 2024

Telisotuzumab vedotin shows promising activity in previously treated, c-Met-overexpressing, EGFR-wild-type nonsquamous non-small cell lung cancer (NSCLC), as presented by CU Cancer Center member David Ross Camidge, MD, PhD, at the ASCO Annual Meeting 2024. This phase 2 LUMINOSITY trial (NCT03539536) involved 161 patients with advanced or metastatic NSCLC and the overall response rate was 28.6%, with median progression-free survival of 5.7 months and median overall survival of 14.5 months.

Full Story
Association of Cancer Care Centers

The Centralized Tracking and Management of Incidental Lung Nodule Findings

news outletAssociation of Cancer Care Centers
Publish DateJune 07, 2024

The University of Colorado Cancer Center has been honored with the 2024 ACCC Innovator Award for creating a community-wide safety net for the centralized tracking and management of incidental lung nodule findings. This innovative approach led to a 2,514% increase in actively managed patients. To handle this surge, the center employs enterprise intelligence software to automatically analyze imaging results and identify high-risk patients, reducing patient wait times from 34 days to 5 days. ACCCBuzz interviewed Nina Thomas, MD, director of the Thoracic Malignancy Pillar, to discuss this achievement.

Full Story